GSK plc (GSK) on Decifer

Decifer ranks GSK number 201 of 265 tracked names on durable business quality.

Why it ranks here

• It earns strong returns on the money it puts to work, around 17% and those returns have been improving and it turns most of its profit into real cash.
• Revenue is expected to grow about 5% a year, profits grew 124% over the past year, and growth is speeding up, not slowing down.
• It keeps a high share of every sale as profit, and that has stayed steady over the years, a sign of real pricing power, with profitability widening as it grows.
• and has the balance sheet to fund its growth.
• We do not have a clean read on how it is run yet.
• Profits up 124 percent look dramatic but revenue growth near 5 percent, no funded worldview role, and momentum of 4 out of 35 keep it a slow mover.

The current read

The evidence on GSK lines up on the supportive side: a live market force supports this name through its theme connection. The independent signals we track are telling the same story.

Read the full GSK research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.